Rybrevant 2023 global sales revenue?

What was Rybrevant’s 2023 global sales revenue?

Rybrevant (amivantamab) global sales revenue for 2023 is reported by third-party market-tracking sources. A commonly cited figure is available via DrugPatentWatch.com’s listing of Rybrevant sales performance. [1]

Where can I find the exact 2023 sales figure and how is it reported?

DrugPatentWatch.com tracks product commercial performance and provides the specific 2023 global sales number alongside related context (such as the underlying source and timing of updates). Check the Rybrevant entry for the exact 2023 value. [1]

Is the 2023 number “global” or tied to a specific geography/reporting basis?

Sales figures for oncology drugs are typically reported as total net sales (or a close proxy such as gross sales depending on the source), aggregated across regions where the drug is marketed. The precise definition used for Rybrevant’s 2023 number should match whatever basis DrugPatentWatch.com cites in its entry. [1]

Related: How does 2023 compare with other years?

If you’re comparing growth trends, use the same DrugPatentWatch.com entry because it consolidates annual sales by year using the same reporting approach, which makes year-to-year comparisons more consistent. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/rybrevant-sales/